COVID - 19
161
12
19
91
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Research Maturity
91 completed trials (57% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.7%
6 terminated out of 161 trials
93.8%
+7.3% vs benchmark
7%
12 trials in Phase 3/4
11%
10 of 91 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 91 completed trials
Clinical Trials (161)
Effect of Pulmonary Rehabilitation and Physical Activity on COVID-19 Long-Term Symptoms (PuReCOVID)
Development of Preterm Infants Born During the COVID-19 Pandemic
Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study
Dapagliflozin for Long COVID Syndrome
Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19
PA-001 Ph.1 Study in Healthy and Elderly Subjects
Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19
COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
Cohort Study of Intraoperative Lung Protective Ventilation Trends in a Large Canadian Health Authority
A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.
Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19
Vitamin E Supplementation As Adjunctive Therapy To Lower Inflammation In COVID-19 Patients
Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda
Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19
Singapore SARS-CoV-2 Human Challenge Study
Covid Flu A/B and RSV 4 in 1 Diagnostic Test
Evaluation of COVID-19 and Flu A/B 3 in 1 Combo Rapid Test
Analysis of Suicidal Behavior Among Children and Adolescents in the Auvergne-Rhone-Alpes Region During the Covid 19 Pandemic Period
Immunogenicity of COVID-19 Vaccine Co-administration With Influenza Vaccine in Healthy Volunteers
Assessement of Effectiveness of Seawater Nasal Sprays on Sinonasal Symptoms